Biodegradation of pharmaceuticals in hospital wastewater by a hybrid biofilm and activated sludge system (Hybas)

Science of the Total Environment

Volumn 530-531, Issue , 2015, Pages 383-392

  Escolà Casas, Mònica ^a   Chhetri, Ravi Kumar ^b   Ooi, Gordon ^a   Hansen, Kamilla M S ^b   Litty, Klaus ^c   Christensson, Magnus ^d   Kragelund, Caroline ^c   Andersen, Henrik R ^b   Bester, Kai ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^c DANISH TECHNOLOGICAL INSTITUTE   (Denmark)

^d AnoxKaldnes Klosterängsvägen 11A ^*  (Sweden)

Author keywords

Hospital wastewater; MBBR; Pharmaceuticals; Removal rate constants; X ray contrast media

Indexed keywords

ANTIBIOTICS; BIODEGRADATION; BIOFILMS; CONTRAST MEDIA; DEGRADATION; DRUG PRODUCTS; HOSPITALS; HYBRID SYSTEMS; PHOTODEGRADATION; PILOT PLANTS; RATE CONSTANTS; WASTEWATER TREATMENT;

ACTIVATED SLUDGE REACTORS; CONTINUOUS-FLOW EXPERIMENTS; DEGRADATION RATE CONSTANTS; HOSPITAL WASTEWATER; MBBR; MOVING BED BIOFILM REACTORS; REMOVAL RATE CONSTANT; X RAY CONTRAST MEDIA;

ACTIVATED SLUDGE PROCESS;

ANALGESIC AGENT; ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CONTRAST MEDIUM; ORGANIC MATTER; DRUG; WASTE WATER; WATER POLLUTANT;

ACTIVATED SLUDGE; BIODEGRADATION; BIOFILM; BIOREACTOR; DRUG; HOSPITAL SECTOR; REACTION KINETICS; WASTEWATER; WATER TREATMENT;

ACTIVATED SLUDGE; ACTIVATED SLUDGE REACTOR; ARTICLE; BATCH PROCESS; BIOFILM; BIOMASS CONVERSION; BIOREACTOR; BIOREMEDIATION; CONTINUOUS PROCESS; CONTROLLED STUDY; DEGRADATION KINETICS; DRUG DEGRADATION; HOSPITAL WASTE; HYBAS REACTOR; MOVING BED BIOFILM REACTOR; NITRIFICATION; PRIORITY JOURNAL; PROCESS TECHNOLOGY; SLUDGE TREATMENT; SYSTEM ANALYSIS; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT; ANALYSIS; CHEMISTRY; GROWTH, DEVELOPMENT AND AGING; HOSPITAL; METABOLISM; MICROBIOLOGY; PROCEDURES; SEWAGE; WASTE WATER; WATER POLLUTANT;

BIODEGRADATION, ENVIRONMENTAL; BIOFILMS; HOSPITALS; PHARMACEUTICAL PREPARATIONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84931274931     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2015.05.099     Document Type: Article

References (44)

1. Antoniou M.G., Hey G., Rodriguez Vega S., Spiliotopoulou A., Fick J., Tysklind M., la Cour Jansen J., Andersen H.R. Required ozone doses for removing pharmaceuticals from wastewater effluents. Sci. Total Environ. 2013, 456-457:42-49.
2. Bester K., Schafer D. Activated soil filters (bio filters) for the elimination of xenobiotics (micro-pollutants) from storm- and waste waters. Water Res. 2009, 43:2639-2646.
3. Bourin M., Jolliet P., Ballereau F. An overview of the clinical pharmacokinetics of x-ray contrast media. Clin. Pharmacokinet. 1997, 32:180-193.
4. Christensson M., Welander T. Treatment of municipal wastewater in a hybrid process using a new suspended carrier with large surface area. Water Sci. Technol. 2004, 49:207-214.
5. Cruz-Morató C., Lucas D., Llorca M., Rodriguez-Mozaz S., Gorga M., Petrovic M., Barceló D., Vicent T., Sarrà M., Marco-Urrea E. Hospital wastewater treatment by fungal bioreactor: removal efficiency for pharmaceuticals and endocrine disruptor compounds. Sci. Total Environ. 2014, 493:365-376.
6. Documed Swiss Compendium of Medicines 2014, https://compendium.ch/home/de.
7. Escolà Casas M., Bester K. Can those organic micro-pollutants that are recalcitrant in activated sludge treatment be removed from wastewater by biofilm reactors (slow sand filters)?. Sci. Total Environ. 2015, 506-507:315-322.
8. Escolà Casas M., Chhetri R.K., Ooi G., Hansen K.M.S., Litty K., Christensson M., Kragelund C., Andersen H.R., Bester K. Biodegradation of pharmaceuticals in hospital wastewater by staged Moving Bed Biofilm Reactors (MBBR). Water Res. 2015, (submitted for publication).
9. Falås P., Baillon-Dhumez A., Andersen H.R., Ledin A., la Cour Jansen J. Suspended biofilm carrier and activated sludge removal of acidic pharmaceuticals. Water Res. 2012, 46:1167-1175.
10. Falås P., Longrée P., la Cour Jansen J., Siegrist H., Hollender J., Joss A. Micropollutant removal by attached and suspended growth in a hybrid biofilm-activated sludge process. Water Res. 2013, 47:4498-4506.
11. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
12. Hapeshi E., Lambrianides A., Koutsoftas P., Kastanos E., Michael C., Fatta-Kassinos D. Investigating the fate of iodinated X-ray contrast media iohexol and diatrizoate during microbial degradation in an MBBR system treating urban wastewater. Environ. Sci. Pollut. Res. Int. 2013, 20:3592-3606.
13. Heberer T., Mechlinski A., Fanck B., Knappe A., Massmann G., Pekdeger A., Fritz B. Field studies on the fate and transport of pharmaceutical residues in bank filtration. Ground Water Monit. Remediat. 2004, 24:70-77.
14. Hekster C.A., Vree T.B. Clinical pharmacokinetics of sulphonamides and their N4-acetyl derivatives. Antibiot. Chemother. (1971) 1982, 31:22-118.
15. Hijosa-Valsero M., Matamoros V., Sidrach-Cardona R., Pedescoll A., Martin-Villacorta J., Garcia J., Bayona J.M., Becares E. Influence of design, physico-chemical and environmental parameters on pharmaceuticals and fragrances removal by constructed wetlands. Water Sci. Technol. 2011, 63:2527-2534.
16. Janzen N., Banzhaf S., Scheytt T., Bester K. Vertical flow soil filter for the elimination of micro pollutants from storm and waste water. Chemosphere 2009, 77:1358-1365.
17. Joss A., Zabczynski S., Gobel A., Hoffmann B., Loffler D., McArdell C.S., Ternes T.A., Thomsen A., Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 2006, 40:1686-1696.
18. Joss A., Siegrist H., Ternes T.A. Are we about to upgrade wastewater treatment for removing organic micropollutants?. Water Sci. Technol. 2008, 57:251-255.
19. Köhler C., Venditti S., Igos E., Klepiszewski K., Benetto E., Cornelissen A. Elimination of pharmaceutical residues in biologically pre-treated hospital wastewater using advanced UV irradiation technology: a comparative assessment. J. Hazard. Mater. 2012, 239-240:70-77.
20. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179:804-817.
21. Kovalova L., Siegrist H., Singer H., Wittmer A., McArdell C.S. Hospital wastewater treatment by membrane bioreactor: performance and efficiency for organic micropollutant elimination. Environ. Sci. Technol. 2012, 46:1536-1545.
22. Kovalova L., Siegrist H., von Gunten U., Eugster J., Hagenbuch M., Wittmer A., Moser R., McArdell C.S. Elimination of micropollutants during post-treatment of hospital wastewater with powdered activated carbon, ozone, and UV. Environ. Sci. Technol. 2013, 47:7899-7908.
23. Li D., Alidina M., Drewes J.E. Role of primary substrate composition on microbial community structure and function and trace organic chemical attenuation in managed aquifer recharge systems. Appl. Microbiol. Biotechnol. 2014, 98:5747-5756.
24. Liu Q., Zhou Y., Chen L., Zheng X. Application of MBR for hospital wastewater treatment in China. Desalination 2010, 250:605-608.
25. Mazumder D. Removal of high organics containing wastewater in a shafttype activated sludge hybrid reactor. Int. J. Environ. Sci. 2010, 1:368-382.
26. Metcalfe C.D., Chu S., Judt C., Li H., Oakes K.D., Servos M.R., Andrews D.M. Antidepressants and their metabolites in municipal wastewater, and downstream exposure in an urban watershed. Environ. Toxicol. Chem. 2010, 29:79-89.
27. Nielsen U., Hastrup C., Klausen M.M., Pedersen B.M., Kristensen G.H., Jansen J.L., Bak S.N., Tuerk J. Removal of APIs and bacteria from hospital wastewater by MBR plus O(3), O(3)+H(2)O(2), PAC or ClO(2). Water Sci. Technol. 2013, 67:854-862.
28. Ødegaard H., Christensson M., Sørensen K. Hybrid systems. Activated Sludge - 100 Years and Counting 2014, IWA Publishing. D. Jenkins, J. Wanner (Eds.).
29. Onesios K., Yu J., Bouwer E. Biodegradation and removal of pharmaceuticals and personal care products in treatment systems: a review. Biodegradation 2009, 20:441-466.
30. Pauwels B., Verstraete W. The treatment of hospital wastewater: an appraisal. J. Water Health 2006, 4:405-416.
31. Pills project: pharmaceutical residues in the aquatic system- a challenge for the future. A European partnership project of: Emschergenossenschaft (DE), Waterschap Groot Salland (NL), Centre de Recherche Public Henri Tudor (LU), Eawag (CH), Glasgow Caledonian University (UK) and Université de Limoges (FR) http://www.pills-project.eu/content/136/documents/PillsBrochure-en.pdf.
32. Randall C.W., Sen D. Full-scale evaluation of an integrated fixed-film activated sludge (IFAS) process for enhanced nitrogen removal. Water Sci. Technol. 1996, 33:155-162.
33. Reungoat J., Escher B.I., Macova M., Keller J. Biofiltration of wastewater treatment plant effluent: effective removal of pharmaceuticals and personal care products and reduction of toxicity. Water Res. 2011, 45:2751-2762.
34. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., Montenegro M.C.B.S.M. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
35. Sathyamoorthy S., Chandran K., Ramsburg C.A. Biodegradation and cometabolic modeling of selected beta blockers during ammonia oxidation. Environ. Sci. Technol. 2013, 47:12835-12843.
36. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Research 1998, 32:3245-3260.
37. Ternes T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol. 2004, 38:392A-399A.
38. Thomas K.V., Dye C., Schlabach M., Langford K.H. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works. J. Environ. Monit. 2007, 9:1410-1418.
39. Timbrell J.A. Principles of Biochemical Toxicology 2009, Informa Helathcare, London.
40. Verlicchi P., Galletti A., Petrovic M., Barceló D. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J. Hydrol. 2010, 389:416-428.
41. Verlicchi P., AlAukidy M., Zambello E. What have we learned from worldwide experiences on the management and treatment of hospital effluent? - an overview and a discussion on perspectives. Sci. Total Environ. 2015, 514:467-491.
42. Vree T.B., de Ven E.S.v., Verwey-van Wissen C.P.W.G.M., Baars A.M., Swolfs A., van Galen P.M., Amatdjais-Groenen H. Isolation, identification and determination of sulfadiazine and its hydroxy metabolites and conjugates from man and Rhesus monkey by high-performance liquid chromatography. J. Chromatography B 1995, 670:111-123.
43. Zearley T.L., Summers R.S. Removal of trace organic micropollutants by drinking water biological filters. Environ. Sci. Technol. 2012, 46:9412-9419.
44. Zupanc M., Kosjek T., Petkovšek M., Dular M., Kompare B., Širok B., Blažeka Ž., Heath E. Removal of pharmaceuticals from wastewater by biological processes, hydrodynamic cavitation and UV treatment. Ultrason. Sonochem. 2013, 20:1104-1112.